7.550
+0,00%
2026-10-08
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -100.5% | -59.4% | 1 / 3 | +5.6% | +1.15 pp | +0.19 pp | +3.9% | 0.49 | 13.22 | 1.129 | +5,6% | 6,9 | +53,1% | 13.22 | 7.25 | +82,3% |
| Pts | 0 | 0 | 4 | 0 | 8 | 8 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.550 (close price on 2026-10-08)EPS (TTM): 571,3
Financial charts
1.Revenue & growth
VND bn1.129Q2/26
1.Revenue & growth
VND bn1.129Q2/26
2.Profit & growth
VND bn14,6Q2/26
3.Profit mix (Penman)
VND bn32,0Q2/26
4.Margins & cost structure
%4.9%Q2/26
5.Returns & cash cycle
% · days3.8%Q2/26
6.Earnings quality & cash
VND bn57,0Q2/26
7.Asset structure
VND bn498Q2/26
8.Funding & debt health
VND bn · times498Q2/26
9.Revenue backlog
VND bn1,69Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %804Q2/26
Adjusted EPS growth, latest quarter
170%
Average adjusted EPS growth, 3 quarters
30.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26